The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 27, 2024
Filed:
Feb. 03, 2023
Genentech, Inc., South San Francisco, CA (US);
Hoffmann-la Roche Inc., Little Falls, NJ (US);
Rene Lebl, Graz, AT;
Ngiap Kie Lim, Dublin, CA (US);
Roland Christoph Meier, Ueken, CH;
Ugo Jonathan Orcel, Basel, CH;
Joerg Sedelmeier, Basel, CH;
Jeff Shen, Foster City, CA (US);
Lauren Elizabeth Sirois, San Francisco, CA (US);
Jacob C. Timmerman, Redwood City, CA (US);
Etienne Trachsel, Basel, CH;
Nicholas Andrew White, San Francisco, CA (US);
Jie Xu, San Mateo, CA (US);
Haiming Zhang, San Mateo, CA (US);
Stephan Bachmann, Allschwil, CH;
Thomas Michael Bass, Fremont, CA (US);
Raphael Bigler, Aarau, CH;
Johannes Adrian Burkhard, Millbrae, CA (US);
Kyle Bradley Pascual Clagg, San Francisco, CA (US);
Francis Gosselin, San Mateo, CA (US);
Chong Han, Foster City, CA (US);
Dainis Kaldre, Lorrach, DE;
Sean M. Kelly, San Mateo, CA (US);
Sebastian Herold, Bad Saeckingen, DE;
Christian Leitner, Eiken, CH;
Genentech, Inc., South San Francisco, CA (US);
Hoffmann-La Roche Inc., Little Falls, NJ (US);
Abstract
Provided herein are methods to synthesize compounds useful in the treatment of cancer where such compounds comprise a quinazolinyl core moiety and at least one stereoisomeric or atropisomeric moiety.